GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Tabula Rasa HealthCare Inc (NAS:TRHC) » Definitions » Intrinsic Value: Projected FCF

Tabula Rasa HealthCare (Tabula Rasa HealthCare) Intrinsic Value: Projected FCF : $-8.80 (As of May. 05, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Tabula Rasa HealthCare Intrinsic Value: Projected FCF?

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.

As of today (2024-05-05), Tabula Rasa HealthCare's Intrinsic Value: Projected FCF is $-8.80. The stock price of Tabula Rasa HealthCare is $10.50. Therefore, Tabula Rasa HealthCare's Price-to-Intrinsic-Value-Projected-FCF of today is 0.0.

The historical rank and industry rank for Tabula Rasa HealthCare's Intrinsic Value: Projected FCF or its related term are showing as below:

During the past 10 years, the highest Price-to-Intrinsic-Value-Projected-FCF of Tabula Rasa HealthCare was 93.98. The lowest was 8.67. And the median was 10.16.

TRHC's Price-to-Projected-FCF is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 1.275
* Ranked among companies with meaningful Price-to-Projected-FCF only.

Tabula Rasa HealthCare Intrinsic Value: Projected FCF Historical Data

The historical data trend for Tabula Rasa HealthCare's Intrinsic Value: Projected FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tabula Rasa HealthCare Intrinsic Value: Projected FCF Chart

Tabula Rasa HealthCare Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Intrinsic Value: Projected FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 4.25 -1.20 -6.98

Tabula Rasa HealthCare Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Intrinsic Value: Projected FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.11 -5.77 -6.98 -8.47 -8.80

Competitive Comparison of Tabula Rasa HealthCare's Intrinsic Value: Projected FCF

For the Health Information Services subindustry, Tabula Rasa HealthCare's Price-to-Projected-FCF, along with its competitors' market caps and Price-to-Projected-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tabula Rasa HealthCare's Price-to-Projected-FCF Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Tabula Rasa HealthCare's Price-to-Projected-FCF distribution charts can be found below:

* The bar in red indicates where Tabula Rasa HealthCare's Price-to-Projected-FCF falls into.



Tabula Rasa HealthCare Intrinsic Value: Projected FCF Calculation

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.

The details of how we calculate the intrinsic value of stocks are described in detail here.

This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + 0.8 * Total Stockholders Equity (most recent) ) / Shares Outstanding (Diluted Average)

In the case of negative Total Stockholders Equity, the following formula is used (see Explanation section below for the reason):

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + Total Stockholders Equity (most recent) / 0.8 ) / Shares Outstanding (Diluted Average)


Add all the Free Cash Flow together and divide 6 will get Tabula Rasa HealthCare's Free Cash Flow(6 year avg) = $-13.24.

Tabula Rasa HealthCare's Intrinsic Value: Projected FCF for today is calculated as

Intrinsic Value: Projected FCF=(Growth Multiple*Free Cash Flow (6 year avg)+Total Stockholders Equity (Jun23)/0.8)/Shares Outstanding (Diluted Average)
=(9.5203515959648*-13.23504+-78.079/0.8)/25.422
=-8.80

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tabula Rasa HealthCare  (NAS:TRHC) Intrinsic Value: Projected FCF Explanation

The growth multiple is capped between 8.35 and 17.74.

Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.

Tabula Rasa HealthCare's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as

Price-to-Intrinsic-Value-Projected-FCF=Share Price/Intrinsic Value: Projected FCF
=10.50/-8.795570143445
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tabula Rasa HealthCare Intrinsic Value: Projected FCF Related Terms

Thank you for viewing the detailed overview of Tabula Rasa HealthCare's Intrinsic Value: Projected FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Tabula Rasa HealthCare (Tabula Rasa HealthCare) Business Description

Traded in Other Exchanges
N/A
Address
228 Strawbridge Drive, Suite 100, Moorestown, NJ, USA, 08057
Tabula Rasa HealthCare Inc is engaged in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk. The cloud-based software solutions of the company help prescribers, pharmacists, and healthcare organizations in managing the medication-related needs of patients. The firm operates the business through two segments namely CareVention HealthCare and MedWise HealthCare.
Executives
Michael Anthony Bruno officer: CHIEF ACCOUNTING OFFICER 1504 PEAR TREE LANE, BENSALEM PA 19020
Derek C Schrier director, 10 percent owner C/O INDABA CAPITAL MANAGEMENT, LLC, ONE LETTERMAN DR., BLDING D, SUITE DM700, SAN FRANCISCO CA 94129
Indaba Capital Fund, L.p. director, 10 percent owner MAPLES CORPORATE SERVICES, 121 SOUTH CHURCH STREET, GRAND CAYMAN E9 KY1-1104
Indaba Capital Management, L.p. director, 10 percent owner ONE LETTERMAN DRIVE, BUILDING D, SUITE DM700, SAN FRANCISCO CA 94129
Ic Gp, Llc director, 10 percent owner ONE LETTERMAN DRIVE,, BUILDING D, SUITE DM700, SAN FRANCISCO CA 94129
Rew Richard W. Ii officer: Chief Legal Officer, Secretary 7000 WEST WILLIAM CANNON, BUILDING ONE, AUSTIN TX 78735
Thomas Cancro officer: CHIEF FINANCIAL OFFICER C/O GFI GROUP INC., NEW YORK NY 10041
Michael J. Purcell director C/O PATRIOT NATIONAL, INC., 401 E. LAS OLAS BLVD., SUITE 1650, FORT LAUDERDALE FL 33301
Ronald Paul Mitchell director 110 W. KINZIE STREET, 5TH FL, CHICAGO IL 60654
Jonathan David Schwartz director 430 EAST 29TH STREET, SUITE 1040, NEW YORK NY 10016
Dennis Helling director 228 STRAWBRIDGE DRIVE, SUITE 100, MOORESTOWN NJ 08057
Michael Greenhalgh officer: Chief Operating Officer 228 STRAWBRIDGE DRIVE, SUITE 100, MOORESTOWN NJ 08057
Gordon Tunstall director
Andrea Carolan Speers officer: Chief Accounting Officer 228 STRAWBRIDGE DRIVE, SUITE 100, MOORESTOWN NJ 08057
Brian W Adams officer: Chief Financial Officer 228 STRAWBRIDGE DRIVE, SUITE 100, MOORESTOWN NJ 08057